SARS-CoV-2 | sciencenewsnet.in

Study Finds That Children’s Immune Response Protects Against COVID-19

September 21, 2020 sarah Jonas Coronavirus, COVID-19, MIS-C, SARS-CoV-2

The first study comparing the immune responses of adults and children with COVID-19 has detected key differences that may contribute to understanding why children usually have milder disease than adults. The findings also have important implications for vaccines and drugs being developed to curb COVID-19. The study was published today in Science Translational Medicine and was conducted by scientists at Albert Einstein College of Medicine, Children’s Hospital at Montefiore (CHAM), and Yale University.

Announcement

CAP adds SARS-CoV-2 antigen testing to its suite of quality assurance programs

September 21, 2020 sarah Jonas COVID-19, laboratory testing, Pathology, Pathology and Laboratory Medicine, SARS-CoV-2

The College of American Pathologists (CAP), in response to continued patient needs in the global COVID-19 pandemic, released a new proficiency testing (PT) program for the detection of antigens of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Announcement

New York State Department of Health Grants Emergency Use Authorization to Mount Sinai for Quantitative COVID-19 Antibody Test

September 17, 2020 sarah Jonas antibody testing, Carlos Cordon-Cardo, covid vaccine, covid-19 immunity, Elisa, Florian Krammer, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, quantitative antibody test, SARS-CoV-2, SARS-CoV-2 antibodies, SARS-CoV-2 virus, serological COVID-19 tests

The Clinical Laboratories of The Mount Sinai Hospital has received emergency use authorization from the New York State Department of Health (NYSDOH) for quantitative use of Mount Sinai’s COVID-19 antibody test, making Mount Sinai’s lab the first in the country to run an authorized, fully quantitative antibody test that can deliver a precise numeric measurement of the level of antibodies in a patient’s blood

Announcement

Introducing COVID19questions.org

September 17, 2020 sarah Jonas Bioinformatics, COVID-19, EHR, Electronic Medical Records, Infectious Disease, Information Management, Pandemic, Public Health, SARS-CoV-2

A consortium of 12 health systems, led by UC San Diego Health, introduces COVID19questions.org, a site where clinicians, researchers, patients and the general public are invited to submit questions that could be answered by COVID-19 patient medical record data from 200+ hospitals.

Feature

Mayo Clinic’s COVID-19 tracking tool provides latest local data, expert guidance

September 17, 2020 sarah Jonas COVID-19, Mayo Clinic, SARS-CoV-2

The number of COVID-19 cases is surging in some regions and retreating in others, making consistent, reliable information and personalized guidance on the pandemic more important than ever.

Research Results

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

September 16, 2020 sarah Jonas COVID-19, SARS-CoV-2, T cells

A multi-layered, virus-specific immune response is important for controlling SARS-CoV-2 during the acute phase of the infection and reducing COVID-19 disease severity, with the bulk of the evidence pointing to a much bigger role for T cells than antibodies.

Research Alert

Mount Sinai Researchers Study SARS-CoV2 caused MIS-C

September 14, 2020 sarah Jonas Multisystem Inflammatory Syndrome in Children, Pediatrics, SARS-CoV-2

In a study published today, entitled Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C), researchers

Research Results

DNA webs may drive lung pathology in severe COVID-19

September 14, 2020 sarah Jonas ARDS, Coronavirus, COVID-19, Neutrophils, SARS-CoV-2

Sticky webs of DNA released from immune cells known as neutrophils may cause much of the tissue damage associated with severe COVID-19 infections, according to two new studies published September 14 in the Journal of Experimental Medicine (JEM). The research, conducted by independent groups in Belgium and Brazil, suggests that blocking the release of these DNA webs could be a new therapeutic target for the management of severe forms of COVID-19.

Announcement

UC Campuses Pilot Google-Apple Notification Technology to Help Prevent COVID-19 Outbreaks

September 11, 2020 sarah Jonas Apps, Bluetooth technology, contact tracing, COVID-19, health tech, Infectious Disease, Patient Privacy, Public Health, SARS-CoV-2

Today, California approved a new voluntary pilot program that uses Apple and Google smartphone technology to help rapidly control COVID-19 outbreaks. The program will launch on the campus of UC San Diego for any students and employees who opt in.

Research Results

UNC Researchers Publish Striking Images of SARS-CoV-2 Infected Cells

September 10, 2020 sarah Jonas COVID-19, SARS-CoV-2

UNC School of Medicine researchers took striking images of the SARS-CoV-2 virus produced by infected respiratory epithelial cells inside human respiratory tract cultures. The New England Journal of Medicine featured this work in its “Images in Medicine” section.

Research Results

Study takes us a step closer to a universal antibody test for COVID-19

September 10, 2020 sarah Jonas Antibodies, blood plasma, blood plasma COVID-19 treatment, convalescent plasma therapy, COVID-19, Immunity, plasma, SARS-CoV-2, SARS-CoV-2 antibodies

A study released by Houston Methodist Sept. 10 in the Journal of Clinical Investigation takes researchers closer to developing a uniform, universal COVID-19 antibody test. The multicenter collaboration tested alternative ways to measure COVID-19 antibody levels that’s faster, easier and can inexpensively be used on a larger scale to accurately identify potential donors for plasma therapy with the best chance of helping patients infected with SARS-CoV-2.

← Previous